Furthermore, there are approximately 40% of pancreatic NETs with mutations in DAXX/ATRX and MEN1, in addition to alternative lengthening of telomeres (ALT), a phenomenon not observed in NECs [5, 7]. Here, MEN1 is linked to pancreatic neuroendocrine tumor.